Informatics and clinical supply chain management: A stronger link for drug development

GREENWICH, CT, September 8 Doug Meyer, Senior Directorfor Aptuit Informatics, discusses the role and importance of informatics intoday's clinical trial environment. The conversation highlightsconsiderations and market factors that companies face when managing clinicalsupplies, the current informatics environment, where the future of this vitalpiece of the drug development puzzle is moving, and its potential impact on adrug development program.

How: The podcast will be accessible for one month via the Aptuithomepage. After this time the podcast will be archived in the media sectionof the resource library. Follow the click path below to listen to thepodcast. Resource library -> Media -> Podcasts

OR

Go to the RSS URL above, and follow the subscription instructions on thewebsite.

About Aptuit

Aptuit, Inc. is a global company focused on streamlining and supportingthe drug development process for biotechnology and pharmaceutical innovators.The company was founded by a group of industry experts with extensive marketexperience who have a track record of building a similar, highly successfulcompany through acquisitions and investment. Aptuit provides a comprehensivesuite of product development services and competencies to more than 800biotechnology and large, fully integrated pharmaceutical innovatorsworldwide. Aptuit's mission is to engineer a better drug development process,and is partnered with Welsh, Carson, Anderson & Stowe, one of the world'slargest private equity investors. For more information about Aptuit, pleasevisit www.aptuit.com.

Minimum Requirements: a computer, an Internet connection, (broadbandrequired), a portable MP3/Video player or MP3/Video-player application onyour computer, podcasting software and QuickTime 7. If you experienceproblems downloading the podcast, send an email to [email protected]: The Podcast is available now for download Where: http://www.aptuit.com OR http://feeds.feedburner.com/aptuit

SOURCE Aptuit, Inc.

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...